Stocks and Investing
Stocks and Investing
Thu, August 10, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Robert Driscoll Reiterated (ZNTL) at Buy and Held Target at $38 on, Aug 10th, 2023
Robert Driscoll of Wedbush, Reiterated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy and Held Target at $38 on, Aug 10th, 2023.
Robert has made no other calls on ZNTL in the last 4 months.
There are 3 other peers that have a rating on ZNTL. Out of the 3 peers that are also analyzing ZNTL, 0 agree with Robert's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Robert
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $50 on, Wednesday, June 7th, 2023
- Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $50 on, Friday, May 26th, 2023
- Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $70 on, Friday, May 19th, 2023
Contributing Sources